MBX Awaits Value-Creating Milestones, With Phase II Hypoparathyroidism Data Due Any Day

Founders Are Pharma Veterans, Repeat Entrepreneurs

 
• By Mandy Jackson
  
MBX has three peptide therapeutics from its PEP platform in or entering the clinic (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business